Integrated analysis of cell cycle-related genes in HR+/HER2- breast cancer.

Jianguo LaiBo ChenYingzi LiXiaoyi LinMin LiJing LiuNing Liao

Published in: Breast cancer (Tokyo, Japan) (2021)

We performed the integrated analysis of the CCGs in HR+/HER2- BC patients. It has the potential to guide individualized precision oncology therapeutic schemes in HR+/HER2- BC patients.

Keyphrases

cell cycle
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
cell proliferation
peritoneal dialysis
risk assessment
patient reported